NFKB1 and non-small cell lung carcinoma: Their findings demonstrated that anti-apoptotic genes, along with the activation of the NF-κB and MAPK pathways, were present in early drug-resistant cells across different NSCLC cell lines, suggesting shared gene expression patterns during the initial stages of resistance.